IncellDx, a company that's marketing a diagnostic and treatment plan for long COVID, says it's not at all associated with the Front Line COVID-19 Critical Care Alliance (FLCCC) after being listed on ...
A team of U.S. clinicians has launched a first-of-its-kind observational study on how repurposed drugs with expired patents, such as ivermectin, might help in treating cancer. The study, led by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback